Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Altratech

Explore full profile

Next Generation Molecular Detection | Bringing together nanotechnology, semiconductors, and fluidics

Cork, IrelandFounded 2013Biotech & Life Sciences
Valuation $10–25M Last recorded · 2021
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Altratech and the history behind them.

About Altratech

Altratech is a forward-thinking startup that operates in the healthcare technology sector. The company has developed a product called UbiHealth, which aims to revolutionize how healthcare services are delivered and managed. UbiHealth is a comprehensive platform designed to streamline patient care, making it more efficient and accessible.

The primary clients of Altratech are healthcare providers, including hospitals, clinics, and individual practitioners. By offering a robust digital solution, Altratech helps these clients manage patient data, appointments, and treatment plans more effectively. This not only improves the quality of care but also enhances operational efficiency.

Altratech operates in the rapidly growing digital health market, which is driven by the increasing demand for innovative healthcare solutions. The company's business model is based on a subscription service, where healthcare providers pay a recurring fee to use the UbiHealth platform. This model ensures a steady stream of revenue and allows for continuous updates and improvements to the platform.

Revenue generation for Altratech comes from these subscription fees, as well as potential add-on services such as advanced analytics, custom integrations, and premium support. By focusing on a subscription-based model, Altratech ensures long-term customer relationships and a predictable revenue stream.

In summary, Altratech is a healthcare technology startup that provides a digital platform called UbiHealth to healthcare providers. It operates in the digital health market and makes money through subscription fees and additional services.

Source: Dealroom company data

At a glance

Founded
2013
Headquarters
Cork, Ireland
Sector
Biotech & Life Sciences

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Enterprise Ireland
  • Kernel Capital
  • European Innovation Council
  • Bill & Melinda Gates Foundation

Series A1 investor entered at this stage

  • Infinity Capital

Series B and later2 investors entered at this stage

  • Claret Capital Partners
  • Bank of Ireland
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇮🇳 India22.2%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Altratech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Altratech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.